EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early health economic assessment of eLi 12 , a new method to estimate 12-h lithium levels when blood sampling deviates from 12 h

Ole Köhler-Forsberg iD, Thea Kirkegaard Kjær iD, Andrew A Nierenberg, Tom Bschor, Lars Vedel Kessing, Christian Kraft, Lars Ehlers

Acta Neuropsychiatrica · 2026 · 38

DOI: 10.1017/neu.2026.10071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropsychiatrica, online erschienen am 06.04.2026. Verfasst von Ole Köhler-Forsberg und 6 weiteren Autor:innen. Beteiligte Einrichtung: Psychosis Research Unit, https://ror.org/040r8fr65Aarhus University Hospital, Denmark. Hauptthemen laut MEDLINE: Bipolar Disorder, Cost-Benefit Analysis, Lithium Compounds, Antimanic Agents. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Early economic evaluations (EEE) can evaluate the economic potential of new innovative healthcare solutions. We present a methodological framework for EEE in bipolar disorder and use eLi 12 as an illustrative case, a new method to estimate 12-h lithium blood levels when blood sampling deviates from the 12-h timing, enabling more flexibility for patients and better data on 12-h lithium levels.

Methods

A decision-analytic model evaluated the costs and consequences of eLi 12 for the treatment of bipolar disorder from a Danish national healthcare payer perspective, assessing the minimum efficacy threshold where eLi 12 would be considered cost-effective compared with standard of care. The primary outcome was net monetary benefit (NMB), and we estimated quality-adjusted life-years (QALYs) assuming a willingness-to-pay threshold of €67,000/QALY gained. Costs associated with bipolar disorder and lithium treatment (e.g. hospitalisations, suicides, lost productivity, implementation costs) were estimated from literature, Danish registries, and expert opinion.

Results

Assuming 28,000 patients with bipolar disorder whereof 10,000 are treated with lithium, a 2.5% reduction in number of hospitalisations and suicides are sufficient for eLi 12 to be considered cost-effective within one year of implementation. When using a longer time horizon, allowing more savings to be included and thus considering a smaller improvement to be sufficient, less than 1% improvement by using eLi 12 would be sufficient within a three-year time horizon.

Conclusion

EEE can evaluate the health economic potential of new innovative methods, supporting early investment decisions and guiding research. eLi 12 can have significant healthcare savings, emphasising the relevance of studying clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderCost-Benefit AnalysisLithium CompoundsAntimanic AgentsLithiumHumansDenmarkCost-Effectiveness AnalysisQuality-Adjusted Life YearsHospitalization

Stichwörter der Autor:innen

12-h lithium levelbipolar disorderearly health economic assessmentlithiumlithium trough level

Substanzen

Lithium CompoundsAntimanic AgentsLithium

Autor:innen und Institutionen

  • Psychosis Research Unit, https://ror.org/040r8fr65Aarhus University Hospital, Denmark.
  • Department of Clinical Medicine, https://ror.org/01aj84f44Aarhus University, Denmark.
  • Nordic Institute of Health Economics A/S, Denmark.
  • Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Harvard Medical School, USA.
  • Departmen of Psychiatry, University Hospital, Technical University of Dresden, Germany.
  • Psychiatric Centre Copenhagen, Denmark.

ORCID-Profile: Ole Köhler-Forsberg, Thea Kirkegaard Kjær

Zitieren

APA

Köhler-Forsberg, O., Kjær, T. K., Nierenberg, A. A., Bschor, T., Kessing, L. V., Kraft, C., & Ehlers, L. (2026). Early health economic assessment of eLi 12 , a new method to estimate 12-h lithium levels when blood sampling deviates from 12 h. Acta Neuropsychiatrica, 38. https://doi.org/10.1017/neu.2026.10071

Vancouver

Köhler-Forsberg O, Kjær TK, Nierenberg AA, Bschor T, Kessing LV, Kraft C, et al. Early health economic assessment of eLi 12 , a new method to estimate 12-h lithium levels when blood sampling deviates from 12 h. Acta Neuropsychiatrica. 2026;38. doi:10.1017/neu.2026.10071

BibTeX
@article{KhlerForsberg2026,
  author = {Köhler-Forsberg, Ole and Kjær, Thea Kirkegaard and Nierenberg, Andrew A and Bschor, Tom and Kessing, Lars Vedel and Kraft, Christian and Ehlers, Lars},
  title = {Early health economic assessment of eLi 12 , a new method to estimate 12-h lithium levels when blood sampling deviates from 12 h},
  journal = {Acta Neuropsychiatrica},
  year = {2026},
  volume = {38},
  doi = {10.1017/neu.2026.10071}
}
Kostenlos starten →